A carregar...
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
The optimal treatment for schizoaffective disorder (SCA) is not well established. In this initial 6-month open-label treatment period of a large, multiphase, relapse-prevention study, the efficacy and safety of paliperidone palmitate once-monthly (PP1M) injectable were evaluated in subjects with sym...
Na minha lista:
| Publicado no: | J Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4932150/ https://ncbi.nlm.nih.gov/pubmed/27322760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000535 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|